Based in Shanghai, BOOKPHARM a pharmaceutical company established with a perfessional pharma team of more than 17 years.

BOOKPHARM mainly work on high-tech biological products of FDF, API and advanced intermediates, can also provide service of Technology Transfer and CDMO/CMO business. BOOKPHARM have co-established biotechnology R&D lab in Shanghai and GMP site in Anhui province, our strong product and service areas:

1. Insulins: Insulin Glargine, Insulin Degludec and Insulin Aspart approved in China;

2. Cagrilintide from US FDA sites in Nanjing and Wuhan;

3. Anti-body Mabs: Trastuzumab, Adalimimab, Bevacizumab, Rituximab, Zuberitamab, Tocilizumab from GMP sites;

4. API and advanced intermediates CDMO/CMO;

5. FDF&API GMP consulting and RA support in EU, US, Brazil and Mexico markets;

6. International M&A consulting service

Worked with more than 200 pharmaceutial partners from all over the world, BOOKPHAM have rich experience and resources in pharmaceutial industry, we continously invest on ESG and wish to bring the best service to all friends and partners and bring more health to the world! You are warmly welcomed to book the best products and service from us!